Kliniska studier för Psoriasis i Texas
8 studier för Psoriasis söker deltagare vid platser i Texas.
Städer i Texas
Officiell studietext (engelska)
A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis
- Precision Comprehensive Research, Colleyville
- Rheumatology Associates of South Texas, San Antonio
RekryterarFas 2
Ålder 18 till 100 · Alla kön · Uppdaterad 25 sep. 2026 · NCT07801495Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
- och 2 fler
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 23 sep. 2026 · NCT03816345Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
- Vanda Investigational Site, San Antonio
- Vanda Investigational Site, Webster
RekryterarFas 3
Ålder 18 till 65 · Alla kön · Uppdaterad 22 sep. 2026 · NCT07362017A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Bellaire Dermatology Associates, Bellaire
- Modern Research Associates, PLLC, Dallas
- Center for Clinical Studies, Houston
- och 3 fler
RekryterarFas 4
Ålder 18 och äldre · Alla kön · Uppdaterad 4 sep. 2026 · NCT06857942A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
- Texas Dermatology and Laser Specialists, San Antonio
- Local Institution - 0280, Southlake
RekryterarFas 3
Ålder 12 till 17 · Alla kön · Uppdaterad 3 sep. 2026 · NCT06979453A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
- Study Center, San Antonio
RekryterarFas 2
Ålder 18 till 70 · Alla kön · Uppdaterad 9 juli 2026 · NCT07489885Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
- M D Anderson Cancer Center, Houston
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 20 maj 2026 · NCT04751396Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis
- Clinical Investigations of Texas, Dallas
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 19 dec. 2025 · NCT06982352Från ClinicalTrials.gov, data hämtad 3 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.